Gonçalo Cardoso1, Carlos Aguiar2, Maria João Andrade2, Lino Patrício3, Isabel Freire4, Fátima Serrano5, Rui Anjos6, Miguel Mendes2. 1. Department of Cardiology, Santa Cruz Hospital, CHLO, Carnaxide, Portugal. Electronic address: goncaloccardoso@gmail.com. 2. Department of Cardiology, Santa Cruz Hospital, CHLO, Carnaxide, Portugal. 3. Department of Cardiology, Santa Marta Hospital, CHLC, Lisbon, Portugal; High-risk Pregnancy Outpatient Clinic, Maternidade Alfredo da Costa, CHLC, Lisbon, Portugal. 4. Department of Clinical Pathology, São Francisco Hospital, CHLO, Lisboa, Portugal. 5. Department of Gynecology and Obstetrics, Maternidade Alfredo da Costa, CHLC, Lisboa, Portugal. 6. Department of Pediatric Cardiology, Santa Cruz Hospital, CHLO, Carnaxide, Portugal.
Abstract
INTRODUCTION: Pregnant women with mechanical prosthetic heart valves are at increased risk for valve thrombosis. Management decisions for this life-threatening complication are complex. Open-heart surgery has a very high risk of maternal mortality and fetal loss. Bleeding and embolic risks associated with thrombolytic agents, the limited efficacy of thrombolysis in certain subgroups, and a lack of experience in the setting of pregnancy raise important concerns. CASE REPORT: We report a case of mitral prosthetic valve thrombosis in early pregnancy, which was successfully treated with streptokinase. Ten years later, the same patient had an uneventful pregnancy, throughout which acenocoumarol was maintained. CONCLUSION: With this case we review the prevention (with oral anticoagulant therapy) and treatment of prosthetic valve thrombosis during pregnancy, which is important for both obstetrician and cardiologist.
INTRODUCTION: Pregnant women with mechanical prosthetic heart valves are at increased risk for valve thrombosis. Management decisions for this life-threatening complication are complex. Open-heart surgery has a very high risk of maternal mortality and fetal loss. Bleeding and embolic risks associated with thrombolytic agents, the limited efficacy of thrombolysis in certain subgroups, and a lack of experience in the setting of pregnancy raise important concerns. CASE REPORT: We report a case of mitral prosthetic valve thrombosis in early pregnancy, which was successfully treated with streptokinase. Ten years later, the same patient had an uneventful pregnancy, throughout which acenocoumarol was maintained. CONCLUSION: With this case we review the prevention (with oral anticoagulant therapy) and treatment of prosthetic valve thrombosis during pregnancy, which is important for both obstetrician and cardiologist.